We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+4.26%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$2.27B
AUM Growth
+$198M
Cap. Flow
+$119M
Cap. Flow %
5.25%
Top 10 Hldgs %
35.16%
Holding
449
New
157
Increased
70
Reduced
62
Closed
148

Top Sells

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$170M
2
TMUS icon
T-Mobile US
TMUS
+$71.2M
3
AAP icon
Advance Auto Parts
AAP
+$34.1M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$27.2M
5
VAL
Valspar
VAL
+$22M

Sector Composition

Rank Sector Weight
1 Consumer Staples 15.94%
2 Healthcare 14.24%
3 Communication Services 13.98%
4 Consumer Discretionary 11.95%
5 Technology 9.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TFX icon
151
Teleflex
TFX
$5.85B
$1.75M 0.08%
8,426
+1,521
+22% +$305K
NEE icon
152
NextEra Energy
NEE
$187B
$1.52M 0.07%
43,388
-263,096
-86% -$8.99M
AKRX
153
DELISTED
Akorn Inc
AKRX
$1.48M 0.07%
+43,610
New +$1.42M
TRCO
154
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
$1.48M 0.07%
+35,980
New +$1.41M
MRK icon
155
Merck
MRK
$324B
$1.41M 0.06%
+23,143
New +$1.41M
AKBA icon
156
Akebia Therapeutics
AKBA
$327M
$1.36M 0.06%
97,294
+44,577
+85% +$565K
CPRT icon
157
Copart
CPRT
$25.9B
$1.35M 0.06%
+169,264
New +$1.3M
LSCC icon
158
Lattice Semiconductor
LSCC
$17.6B
$1.35M 0.06%
192,295
-50,573
-21% -$346K
KEYS icon
159
Keysight
KEYS
$54.5B
$1.34M 0.06%
34,418
-12,300
-26% -$464K
SD icon
160
SandRidge Energy
SD
$510M
$1.34M 0.06%
+78,876
New +$1.47M
SEE
161
DELISTED
Sealed Air
SEE
$1.33M 0.06%
29,519
+21,805
+283% +$962K
BIIB icon
162
Biogen
BIIB
$29.9B
$1.29M 0.06%
4,778
+1,420
+42% +$375K
SFM icon
163
Sprouts Farmers Market
SFM
$7.04B
$1.29M 0.06%
+56,142
New +$1.3M
AET
164
DELISTED
Aetna Inc
AET
$1.29M 0.06%
8,487
+1,005
+13% +$142K
ZNGA
165
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$1.29M 0.06%
321,816
-213,033
-40% -$699K
EEFT icon
166
Euronet Worldwide
EEFT
$3.02B
$1.28M 0.06%
+14,732
New +$1.26M
EW icon
167
Edwards Lifesciences
EW
$47.6B
$1.28M 0.06%
32,496
-23,556
-42% -$860K
KEY icon
168
KeyCorp
KEY
$24.3B
$1.28M 0.06%
67,174
-24,610
-27% -$445K
COHR
169
DELISTED
Coherent Inc
COHR
$1.27M 0.06%
+5,641
New +$1.3M
NVS icon
170
Novartis
NVS
$295B
$1.26M 0.06%
+16,929
New +$1.2M
VMC icon
171
Vulcan Materials
VMC
$36.3B
$1.26M 0.06%
9,897
-4,299
-30% -$540K
MSI icon
172
Motorola Solutions
MSI
$69.4B
$1.25M 0.06%
+14,405
New +$1.22M
MSCC
173
DELISTED
Microsemi Corp
MSCC
$1.25M 0.06%
26,617
+5,011
+23% +$245K
LBRDK icon
174
Liberty Broadband Class C
LBRDK
$4.15B
$1.25M 0.06%
+14,347
New +$1.25M
PANW icon
175
Palo Alto Networks
PANW
$264B
$1.24M 0.05%
+55,680
New +$1.12M

Similar funds

Marshall Wace's Q2 2017 Portfolio in Review

As of Q2 2017, Marshall Wace held 449 positions worth $2.27B, up 9.6% from $2.07B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Marshall Wace deployed $119M of net new capital in Q2 2017, opening 157 new positions and adding to 70 existing holdings. Its largest new stake was State Street Health Care Select Sector SPDR ETF: 742,458 shares worth $58.7M.

By sector, the portfolio is most concentrated in Consumer Staples at 16% of assets, up from 11% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Zoetis, an estimated $170M trimmed.

  • Marshall Wace's largest Q2 2017 buy was State Street Health Care Select Sector SPDR ETF: 742,458 shares worth $58.7M.
  • Marshall Wace added most to Reynolds American Inc in Q2 2017, an estimated $84.2M increase.
  • Marshall Wace's biggest Q2 2017 reduction was Zoetis, cutting an estimated $170M.
  • Marshall Wace fully exited Advance Auto Parts in Q2 2017, selling an estimated $34.1M.
  • Marshall Wace's ten largest holdings make up 35% of its $2.27B portfolio in Q2 2017.
  • Marshall Wace opened 157 new positions and closed 148 in Q2 2017.
  • Marshall Wace's portfolio value rose 9.6% quarter-over-quarter to $2.27B.

Based on Marshall Wace's 13F filing for Q2 2017, filed 4 Aug 2017.